Search hospitals > Colorado > Colorado Springs
Penrose-Saint Francis Healthcare
Claim this profileColorado Springs, Colorado 80907
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Non-Small Cell Lung Cancer
316 reported clinical trials
3 medical researchers
Summary
Penrose-Saint Francis Healthcare is a medical facility located in Colorado Springs, Colorado. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Non-Small Cell Lung Cancer and other specialties. Penrose-Saint Francis Healthcare is involved with conducting 316 clinical trials across 436 conditions. There are 3 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, and Mehmet S. Copur.Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Richard L. DemingMercy Medical Center - Des Moines6 years of reported clinical research
Expert in Breast Cancer
Expert in Cancer
178 reported clinical trials
242 drugs studied
Shahzad SiddiquePenrose-Saint Francis Healthcare2 years of reported clinical research
Expert in Breast Cancer
Expert in Cancer
124 reported clinical trials
187 drugs studied
Mehmet S. CopurBethesda North Hospital13 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
3 reported clinical trials
14 drugs studied
Clinical Trials running at Penrose-Saint Francis Healthcare
Lung Cancer
Bladder Cancer
Breast Cancer
Prostate Cancer
Breast cancer
Ovarian Cancer
Esophageal cancer
Pancreatic Cancer
Multiple Myeloma
Colorectal Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting2 awards Phase 34 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Penrose-Saint Francis Healthcare?
Penrose-Saint Francis Healthcare is a medical facility located in Colorado Springs, Colorado. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Non-Small Cell Lung Cancer and other specialties. Penrose-Saint Francis Healthcare is involved with conducting 316 clinical trials across 436 conditions. There are 3 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, and Mehmet S. Copur.
Where is Penrose-Saint Francis Healthcare located?
Penrose-Saint Francis Healthcare is located at 2222 N Nevada Ave, Colorado Springs, CO 80907, near the intersection of Circle Drive and Union Boulevard. It is directly across from the Audubon Medical Campus and Medical Center Point.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Penrose-Saint Francis Healthcare, contact the Financial Counseling department at 719-776-7489. For billing or payment inquiries, call the customer service line at 303-381-1549. Additionally, for further assistance with billing and financial services, email Centura Health at ptaccessbillingissues@centura.org or call 303-486-5400 or 800-953-0104.
What insurance does Penrose-Saint Francis Healthcare accept?
Penrose-Saint Francis Healthcare, part of the Centura Health system, accepts various insurance plans, including Medicare and Medicaid, and welcomes most major insurances. For a detailed list of accepted insurance plans, contacting the hospital directly or visiting their official website is recommended. Insurance networks are subject to change, so confirming coverage with your provider for specific procedures and facilities is advised.
What awards or recognition has Penrose-Saint Francis Healthcare received?
Penrose-Saint Francis Healthcare, located in Colorado Springs, Colorado, has been recognized as one of America's 50 best hospitals by Healthgrades in 2017 and one of America's 250 best hospitals in 2022. It is a part of CommonSpirit Health, dedicated to delivering high-quality healthcare services to the community.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.